Contents
Download PDF
82 Views
600 Downloads
Share this article
Research Article | Volume 29 Issue:1 (Jan-March, 2024) | Pages 24 - 29
Multiple sclerosis patients CCL5 levels
 ,
1
College of science, Kufa University, Iraq
Under a Creative Commons license
Open Access
Received
Dec. 14, 2023
Revised
Jan. 1, 2024
Accepted
Feb. 16, 2024
Published
March 30, 2024
Abstract

Aim of study multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system (CNS). This study aims to examine the CCL5 values in patients with Multiple Sclerosis. Patients and methodsA retrospective study was undertaken on 70 individuals diagnosed with multiple sclerosis utilising archived material. The RNA sequence of CCL5 was analysed using the real-time polymerase chain reaction (qPCR) technique. The CCL5 level was determined using quantitative polymerase chain reaction (RT-PCR) methodology. Results in total, a collection of 70 samples was obtained. The concentration of CCL5 was identified in all seventy patients and subsequently compared with a set of 30 control samples. There is an observed increase in the levels of CCL5 in patients diagnosed with Multiple Sclerosis (M.S) compared to individuals in good condition. Conclusion these findings provide support for the elevated levels of CCL5 observed in patients with Multiple Sclerosis. Moreover, compared to control cases, it appears that CCL5 correlates with a more unfavourable outcome in patients.

Recommended Articles
Short Commentary Article
Aortic valve implantation techniques--should they be any different for the pulmonary autograft and the aortic homograft?
Published: 21/09/2023
Download PDF
Research Article
Study to Assess the Effectiveness of Cell Block Technique in Analysis of Pleural Fluids Among Pleural Effusion Cases
...
Published: 31/03/2024
Download PDF
Case Report
Complejo Asistencial Universitario de León, León, Spain.
...
Download PDF
Research Article
The 'Pomeroy procedure': a new method to correct post-mitral valve repair systolic anterior motion
...
Published: 12/07/2001
Download PDF
Copyright © iARCON International LLP. All Rights Reserved.